Ayr Wellness Inc.
AYRWF • Drug Manufacturers - Specialty & Generic
$0.00
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$432,063.8
Growth
60.5%
Cash Flow
1/5
Trend
Volatile
Evidence
Healthy liquidity · 1.6Negative growth trendWeak profitability
Financial data as of: Mar 31, 2025, 12:00 AM UTCLast earnings update: Mar 31, 2025, 12:00 AM UTCLast profile update: Sep 2, 2026, 12:18 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Shares Out116.77M
Market Cap$432.06K
Enterprise Value$379.23M
52W Range0.00 - 0.10
Beta1.02
P/E-0.00
P/S0.00
P/B0.00
P/FCF-0.08
EV/Sales0.84
Price$0.00
Change0.00%
Shares Out116.77M
Market Cap$432.06K
Enterprise Value$379.23M
52W Range0.00 - 0.10
Beta1.02
P/E-0.00
P/S0.00
P/B0.00
P/FCF-0.08
EV/Sales0.84
EV/EBITDA-3.94
EV/FCF-67.49
Dividend Yield0.00%
Gross Margin38.11%
Oper. Margin-34.72%
Profit Margin-77.50%
Debt/Eq1.64
Current Ratio1.60
Quick Ratio0.57
Revenue 5Y60.51%
Target$1.00
Target Upside26927.03%
Target Median$1.00
Target Range1.00 - 1.00
Volume19.00K
Avg Volume188.70K
EPS Surprise-0.09
Investment DNA
How strong this company looks for long-term investors
38
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Healthy liquidity · 1.6Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
83/100
Bullish
Bullish
2
Hold
1
Bearish
0
Price Target
2026-09-02
Low
$1.00
Mean
$1.00
Median
$1.00
High
$1.00
🧾
No insider activity
No recent insider transactions available.